Patents by Inventor Piotr Golebiewski

Piotr Golebiewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7897793
    Abstract: The invention relates to a process for the preparation of 13,14-dihydro-PGF2? derivatives of R or S configuration at carbon 15, represented by the general formula (I), wherein the identity of the substituents is defined in the description. Compounds of the formula (I) are valuable biologically-active substances or intermediates in the preparation thereof. The invention especially relates to the process for preparation of 13,14-dihydro-15(R)-17-substituted-18,19,20-trinor-PGF2?, i.e., latanoprost.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: March 1, 2011
    Assignee: Instytut Farmaceutyczny
    Inventors: Jacek Martynow, Julita Szyc, Wieslaw Szelejewski, Osman Achmatowicz, Andrzej Kutner, Krzysztof Wiśniewski, Jerzy Winiarski, Oliwia Zegrocka-Stendel, Piotr Golebiewski
  • Publication number: 20090093651
    Abstract: The invention relates to a process for the preparation of 13,14-dihydro-PGF2? derivatives of R or S configuration at carbon 15, represented by the general formula (I), wherein the identity of the substituents is defined in the description. Compounds of the formula (I) are valuable biologically-active substances or intermediates in the preparation thereof. The invention especially relates to the process for preparation of 13,14-dihydro-15(R)-17-substituted-18,19,20-trinor-PGF2?, i.e., latanoprost.
    Type: Application
    Filed: April 18, 2006
    Publication date: April 9, 2009
    Applicant: INSTYTUT FARMACEUTYCZNY
    Inventors: Jacek Martynow, Julita Szyc, Wieslaw Szelejewski, Osman Achmatowicz, Andrzej Kutner, Krzysztof Wisniewski, Jerzy Winiarski, Oliwia Zegrocka-Stendel, Piotr Golebiewski
  • Publication number: 20080207926
    Abstract: The invention relates to a process for the preparation of 13,14-dihydro-PGF2? derivatives of R or S configuration at carbon 15, represented by the general formula (I), wherein the identity of the substituents is defined in the description. Compounds of the formula (I) are valuable biologically-active substances or intermediates in the preparation thereof. The invention especially relates to the process for preparation of 13,14-dihydro-15(R)-17-substituted-18,19,20-trinor-PGF2?, i.e., latanoprost.
    Type: Application
    Filed: October 18, 2007
    Publication date: August 28, 2008
    Applicant: INSTYTUT FARMACEUTYCZNY
    Inventors: Jacek MARTYNOW, Julita SZYC, Wieslaw SZELEJEWSKI, Osman ACHMATOWICZ, Andrzej KUTNER, Krzysztof WISNIEWSKI, Jerzy WINIARSKI, Oliwia ZEGROCKA-STENDEL, Piotr GOLEBIEWSKI